Back
Cormedix 10K Form
Sell
33
CRMD
Cormedix
Last Price:
9.78
Seasonality Move:
47.98%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-11-14 | 10Q | CRMD/Cormedix Quarterly |
2023-08-08 | 10Q | CRMD/Cormedix Quarterly |
2023-05-15 | 10Q | CRMD/Cormedix Quarterly |
2022-11-10 | 10Q | CRMD/Cormedix Quarterly |
2022-08-11 | 10Q | CRMD/Cormedix Quarterly |
2022-05-12 | 10Q | CRMD/Cormedix Quarterly |
Receive CRMD News And Ratings
See the #1 stock for the next 7 days that we like better than CRMD
CRMD Financial Statistics
Sales & Book Value
Annual Sales: | $65.41K |
---|---|
Cash Flow: | $-13.66M |
Price / Cash Flow: | 0 |
Annual Sales: | $1.01 |
Price / Book: | 10.11 |
Profitability
EPS (TTM): | -0.81000 |
---|---|
Net Income (TTM): | $-46.15M |
Gross Margin: | $0 |
Return on Equity: | -72.96% |
Return on Assets: | -61.23% |
Cormedix Earnings Forecast
Key Cormedix Financial Ratios
- The Selling, General & Administrative Expenses for CRMD have been equal to 30,585.67% of Gross Profit Margin.
- The Interest Expense is -0.07% of Operating Income.
- Per Share Earnings over the last 15 years have been positive in 9 years.
Cormedix Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | CRMD |
CUSIP: | 21900C |
Website: | cormedix.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 3.96 |
Quick Ratio: | 3.43 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 20.38 |